Free shipping on all orders over $ 500

AbMole Products Use Citations


Targeting Ribonucleotide Reductase to Enhance the Antileukemic Activity of Gilteritinib Against Chemoresistant FLT3-ITD AML
【IF: 0】ASPET Discovery. 2025 Sep 03;   Z-VAD-FMK purchased from AbMole

Patent. WO2025176679A1
【IF: 0】Patent. WO2025176679A1 2025 Aug 28;   Crizotinib hydrochloride purchased from AbMole

Patent. CN121087118A
【IF: 0】Patent. CN121087118A 2025 Dec 09;   Urolithin M7 purchased from AbMole

Patent. CN119138406B
【IF: 0】Patent. CN119138406B 2025 Mar 07;   Recombinant Human IL-4 Protein (CHO, C-Fc) purchased from AbMole

Patent. CN119679916A
【IF: 0】Patent. CN119679916A 2025 Mar 25  Angiotensin II human purchased from AbMole

Patent. CN119367339A
【IF: 0】Patent. CN119367339A 2025-01-28  Dorsomorphin dihydrochloride purchased from AbMole

In vivo interaction screening reveals liver-derived constraints to metastasis
【IF: 50.5】Nature. 2024 Jul 24;632(8024):411-418  Y-27632 dihydrochloride purchased from AbMole

Improved detection of colibactin-induced mutations by genotoxic E. coli in organoids and colorectal cancer
【IF: 50.3】Cancer Cell. 2024 Mar 11;42(3):487-496  Y-27632 dihydrochloride purchased from AbMole

Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer
【IF: 50.3】Cancer Cell. 2024 Apr 8;42(4):535-551.e8  A 83-01 purchased from AbMole

Decoding transcriptional identity in developing human sensory neurons and organoid modeling
【IF: 45.5】Cell. 2024 Dec 26;187(26):7374-7393.e28  CHIR-99021 purchased from AbMole

Amplification editing enables efficient and precise duplication of DNA from short sequence to megabase and chromosomal scale
【IF: 45.5】Cell. 2024 Jul 01  XL-184 purchased from AbMole

Human fetal brain self-organizes into long-term expanding organoids
【IF: 45.5】Cell. 2024 Feb 1;187(3):712-732.e38  Y-27632 dihydrochloride purchased from AbMole




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.